Upcoming catalysts and material SEC filings for BridgeBio Pharma, Inc. (BBIO). 1 upcoming catalyst.
FDA decision date
Nov 27, 2026 · Confirmed
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
SEC EDGAR · 17d ago